Login / Signup

An Oxidative Bioconjugation Strategy Targeted to a Genetically Encoded 5-Hydroxytryptophan.

Partha Sarathi AddyJames S ItaliaAbhishek Chatterjee
Published in: Chembiochem : a European journal of chemical biology (2018)
Approaches that enable the chemoselective, covalent modification of proteins in a site-specific manner have emerged as a powerful technology for a wide range of applications. The electron-rich unnatural amino acid 5-hydroxytryptophan was recently genetically encoded in both Escherichia coli and eukaryotes, thereby allowing its site-specific incorporation into virtually any recombinant protein. Herein, we report the chemoselective conjugation of various aromatic amines to full-length proteins under mild, oxidative conditions that target this site-specifically incorporated 5-hydroxytryptophan residue.
Keyphrases
  • amino acid
  • escherichia coli
  • cancer therapy
  • small molecule
  • drug delivery
  • cell free
  • staphylococcus aureus
  • klebsiella pneumoniae
  • biofilm formation
  • pseudomonas aeruginosa